Medical Excellence For You


Your access to the most innovative laboratory services

UPDATES: SARS-CoV-2

SYNLAB Investor Relations

Your health matters.

We are there to support you with highly efficient, evidence-based and state-of-the-art diagnostic technology. Our scientific experts provide consultation on individual diagnostic pathways and meaningful and valid interpretation of results. This creates a solid foundation to deliver efficient and effective therapy. And because we want you to get – and stay – well, we work together with an international network of experts to accelerate development of new diagnostic procedures. Every day.
Welcome to the world of SYNLAB. Get to know us.

Watch the video on vimeo.com  

Press releases
  • myEDIT-B is the world’s first clinically validated test for the differential diagnosis between bipolar disorder and unipolar depression
  • myEDIT-B reduces time to diagnosis of bipolar disorder within 4 weeks from the blood drawn, expediting the…
Read more
Press releases
  • SYNLAB’s myEDIT-B is the world’s first blood-based test for the…
Read more
Press releases
  • Cinven to launch public acquisition offer to all shareholders…
Read more
Press releases

SYNLAB agrees to sell its veterinary diagnostics business to Mars

SYNLAB (FSE: SYAB), the leader in medical diagnostic services and specialty testing in Europe, has agreed to sell its veterinary diagnostics business (SYNLAB VET) to Mars Incorporated (Mars). The…

Read more

Contact us

Do you have a question or a request? We will handle your request as soon as possible and get in touch with you.

Labs & Locations

Represented in more than 30 countries on four continents and with around 27,000 employees, we are always close to you.

Our local country websites

Do you have a question or a request? Find your local contact person on our country websites.